• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.

作者信息

Al Jurdi Ayman, Gassen Rodrigo B, Borges Thiago J, Lape Isadora T, Morena Leela, Efe Orhan, Solhjou Zhabiz, El Fekih Rania, Deban Christa, Bohan Brigid, Pattanayak Vikram, Kotton Camille N, Azzi Jamil R, Riella Leonardo V

机构信息

Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, MA, USA.

Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.

DOI:10.1016/j.kint.2022.04.009
PMID:35429496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9006415/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5402/9006415/2ce1398c6f85/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5402/9006415/9d3f3c538dd6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5402/9006415/2ce1398c6f85/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5402/9006415/9d3f3c538dd6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5402/9006415/2ce1398c6f85/gr2_lrg.jpg

相似文献

1
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.肾移植受者在接种第三剂mRNA疫苗后对新冠病毒奥密克戎变异株的抗体反应欠佳。
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
2
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.肾移植受者接种第三剂 mRNA SARS-CoV-2 疫苗后对 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株的中和抗体反应。
Am J Transplant. 2022 Jul;22(7):1873-1883. doi: 10.1111/ajt.17054. Epub 2022 Apr 18.
3
Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients.在接受mRNA疫苗初免的肾移植受者中，第三剂异源载体疫苗Ad26.COVS1接种后SARS-CoV-2抗体反应增强。
Transpl Int. 2022 Mar 22;36:10357. doi: 10.3389/ti.2022.10357. eCollection 2022.
4
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.肾移植受者同源与异源第三剂疫苗接种后 4 周时的 SARS-CoV-2 抗体反应比较：一项随机临床试验。
JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372.
5
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
6
The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.SARS-CoV-2 疫苗的种类会影响肾移植受者的血清学反应。
Clin Transplant. 2022 Apr;36(4):e14585. doi: 10.1111/ctr.14585. Epub 2022 Jan 18.
7
Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.肾移植受者对SARS-CoV-2 mRNA疫苗的抗体反应
Exp Clin Transplant. 2022 Nov;20(11):1048. doi: 10.6002/ect.2022.0176.
8
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.肾移植受者接种第三剂 SARS-CoV-2 疫苗后的体液免疫反应。
Transplant Proc. 2022 Jul-Aug;54(6):1439-1445. doi: 10.1016/j.transproceed.2022.02.011. Epub 2022 Mar 1.
9
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.严格血清阴性肾移植受者中的第四种SARS-CoV-2 mRNA疫苗。
Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
10
Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.青少年实体器官移植受者对三种SARS-CoV-2 mRNA疫苗的抗体反应。
Am J Transplant. 2022 Oct;22(10):2481-2483. doi: 10.1111/ajt.17085. Epub 2022 May 13.

引用本文的文献

1
Correlates of SARS-CoV-2 Breakthrough Infections in Kidney Transplant Recipients Following a Third SARS-CoV-2 mRNA Vaccine Dose.肾移植受者接种第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗后SARS-CoV-2突破性感染的相关因素
Vaccines (Basel). 2025 Jul 22;13(8):777. doi: 10.3390/vaccines13080777.
2
Comparison of Post-Vaccination Response (Humoral and Cellular) to BNT162b2 in Clinical Cases, Kidney and Pancreas Transplant Recipient with Immunocompetent Subjects over Almost Two Years of Parallel Monitoring.在近两年的平行监测中，对临床病例、肾和胰腺移植受者以及免疫功能正常的受试者接种BNT162b2后的反应（体液和细胞反应）进行比较。
Vaccines (Basel). 2024 Jul 26;12(8):844. doi: 10.3390/vaccines12080844.
3

本文引用的文献

1
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.第三剂 SARS-CoV-2 疫苗可提高实体器官移植受者对关注变异株的中和抗体。
Am J Transplant. 2022 Apr;22(4):1253-1260. doi: 10.1111/ajt.16933. Epub 2022 Jan 18.
2
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.免疫后血清对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎B.1.1.529变体的中和作用降低。
Lancet. 2022 Jan 15;399(10321):234-236. doi: 10.1016/S0140-6736(21)02844-0. Epub 2021 Dec 20.
3
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.
mRNA 疫苗接种后肾移植受者对 SARS-CoV-2 奥密克戎亚变种的中和抗体反应和细胞反应。
Sci Rep. 2024 May 28;14(1):12176. doi: 10.1038/s41598-024-63147-z.
4
Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients.mRNA-1273 新型冠状病毒病 2019 疫苗在实体器官移植受者中的安全性和免疫原性。
J Infect Dis. 2024 Sep 23;230(3):e591-e600. doi: 10.1093/infdis/jiae140.
5
Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis.HIV感染者中新冠病毒加强针疫苗接种的免疫原性和有效性：一项系统评价与荟萃分析
Front Med (Lausanne). 2023 Oct 9;10:1275843. doi: 10.3389/fmed.2023.1275843. eCollection 2023.
6
What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms.有哪些当前的抗 COVID-19 药物？从传统到智能的分子机制。
Virol J. 2023 Oct 24;20(1):241. doi: 10.1186/s12985-023-02210-z.
7
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.一种靶向T细胞的多抗原疫苗可产生针对新冠病毒感染的强大细胞免疫和体液免疫。
Mol Ther Methods Clin Dev. 2023 Sep 16;31:101110. doi: 10.1016/j.omtm.2023.101110. eCollection 2023 Dec 14.
8
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.ABO 血型不相容的肾移植受者接受低剂量利妥昔单抗治疗后对 SARS-CoV-2 mRNA 疫苗的体液反应。
Sci Rep. 2023 Sep 12;13(1):15098. doi: 10.1038/s41598-023-42406-5.
9
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.实体器官移植受者对 SARS-CoV-2 感染的易感性和对 COVID-19 疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S34-S45. doi: 10.1093/infdis/jiad152.
10
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients.在一个大型肾移植受者队列中，三种剂量的 SARS-CoV-2 mRNA 疫苗接种后的体液免疫应答动力学和感染严重程度。
J Nephrol. 2023 Jul;36(6):1663-1671. doi: 10.1007/s40620-023-01650-8. Epub 2023 Jul 17.
SARS-CoV-2 B.1.617.2 德尔塔变异株复制和免疫逃逸。
Nature. 2021 Nov;599(7883):114-119. doi: 10.1038/s41586-021-03944-y. Epub 2021 Sep 6.
4
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.肾移植受者和透析患者对 SARS-CoV-2 BNT162b2 疫苗的体液免疫受损。
Sci Immunol. 2021 Jun 15;6(60). doi: 10.1126/sciimmunol.abj1031.
5
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
6
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.接受2剂mRNA-1273新型冠状病毒疫苗的肾移植受者中免疫接种率较低。
Kidney Int. 2021 Jun;99(6):1498-1500. doi: 10.1016/j.kint.2021.04.005. Epub 2021 Apr 20.
7
Is COVID-19 infection more severe in kidney transplant recipients?新冠病毒（COVID-19）感染在肾移植受者中更严重吗？
Am J Transplant. 2021 Mar;21(3):1295-1303. doi: 10.1111/ajt.16424. Epub 2021 Jan 28.